132 related articles for article (PubMed ID: 24702231)
1. Alpha B-crystallin - a validated prognostic factor for poor prognosis in squamous cell carcinoma of the oral cavity.
Annertz K; Enoksson J; Williams R; Jacobsson H; Coman WB; Wennerberg J
Acta Otolaryngol; 2014 May; 134(5):543-50. PubMed ID: 24702231
[TBL] [Abstract][Full Text] [Related]
2. Alpha B-crystallin, a new independent marker for poor prognosis in head and neck cancer.
Chin D; Boyle GM; Williams RM; Ferguson K; Pandeya N; Pedley J; Campbell CM; Theile DR; Parsons PG; Coman WB
Laryngoscope; 2005 Jul; 115(7):1239-42. PubMed ID: 15995513
[TBL] [Abstract][Full Text] [Related]
3. High-risk HPV and survival in patients with oral and oropharyngeal squamous cell carcinoma - 5-year follow up of a population-based study.
Annertz K; Rosenquist K; Andersson G; Jacobsson H; Hansson BG; Wennerberg J
Acta Otolaryngol; 2014 Aug; 134(8):843-51. PubMed ID: 24930912
[TBL] [Abstract][Full Text] [Related]
4. Is alpha-B crystallin an independent marker for prognosis in lung cancer?
Campbell-Lloyd AJ; Mundy J; Deva R; Lampe G; Hawley C; Boyle G; Griffin R; Thompson C; Shah P
Heart Lung Circ; 2013 Sep; 22(9):759-66. PubMed ID: 23582651
[TBL] [Abstract][Full Text] [Related]
5. [Expression and significance of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx].
Zhao EM; Han DM; Yu ZK; Fan EZ; Li Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):39-42. PubMed ID: 12778766
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of the urokinase-type plasminogen activator and its inhibitors in squamous cell carcinoma of human larynx].
Zhao E; Han D; Yu Z; Fan E; Li Y; Zhou Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Nov; 16(11):599-602. PubMed ID: 15515548
[TBL] [Abstract][Full Text] [Related]
7. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
8. Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity - clinical relevance and prognostic value.
Hundsdorfer B; Zeilhofer HF; Bock KP; Dettmar P; Schmitt M; Kolk A; Pautke C; Horch HH
J Craniomaxillofac Surg; 2005 Jun; 33(3):191-6. PubMed ID: 15878520
[TBL] [Abstract][Full Text] [Related]
9. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
[TBL] [Abstract][Full Text] [Related]
10. Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase-2 and sialyl Lewis x antigen.
Gunawardena I; Arendse M; Jameson MB; Plank LD; Gregor RT
ANZ J Surg; 2015 Nov; 85(11):843-8. PubMed ID: 24171785
[TBL] [Abstract][Full Text] [Related]
11. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC
Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.
Werle B; Kotzsch M; Lah TT; Kos J; Gabrijelcic-Geiger D; Spiess E; Schirren J; Ebert W; Fiehn W; Luther T; Magdolen V; Schmitt M; Harbeck N
Anticancer Res; 2004; 24(6):4147-61. PubMed ID: 15736466
[TBL] [Abstract][Full Text] [Related]
13. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
[TBL] [Abstract][Full Text] [Related]
14. High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity.
Züllig L; Roessle M; Weber C; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H; Huber GF
Eur J Cancer; 2013 May; 49(8):1915-22. PubMed ID: 23414798
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.
Speleman L; Kerrebijn JD; Look MP; Meeuwis CA; Foekens JA; Berns EM
Head Neck; 2007 Apr; 29(4):341-50. PubMed ID: 17163465
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma.
Capote-Moreno A; Naval L; Muñoz-Guerra MF; Sastre J; Rodríguez-Campo FJ
J Oral Maxillofac Surg; 2010 Feb; 68(2):268-75. PubMed ID: 20116694
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases.
Carlos de Vicente J; Junquera Gutiérrez LM; Zapatero AH; Fresno Forcelledo MF; Hernández-Vallejo G; López Arranz JS
Head Neck; 2004 Jan; 26(1):22-30. PubMed ID: 14724903
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor receptor (p75 NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma.
Søland TM; Brusevold IJ; Koppang HS; Schenck K; Bryne M
Histopathology; 2008 Jul; 53(1):62-72. PubMed ID: 18540978
[TBL] [Abstract][Full Text] [Related]
19. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
20. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis.
Laimer K; Spizzo G; Gastl G; Obrist P; Brunhuber T; Fong D; Barbieri V; Jank S; Doppler W; Rasse M; Norer B
Oral Oncol; 2007 Feb; 43(2):193-8. PubMed ID: 16854613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
